1 / 1

Immunomodulators Market Size & Share

Immunomodulators Market Size & Share

Manisha109
Télécharger la présentation

Immunomodulators Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The immunomodulators market is projected to grow from $186.12 billion in 2020 to $285.01 billion by 2027, with a compound annual growth rate of 6.3%. North America leads the market with a 38.32% share, driven by robust research and development in treating conditions like multiple sclerosis, rheumatoid arthritis, and Crohn's disease. Key market segments include:  Immunosuppressants (largest segment)  Immunostimulants (fastest growing segment, projected to reach $119 billion by 2025) Major developments shaping the market:  COVID-19 had a positive impact, with companies improving supply chain management and R&D capabilities  Strong drug pipeline development, including new treatments from Biogen, Roche, and Teva Pharmaceuticals  Increasing prevalence of autoimmune diseases driving demand  Rising focus on cancer immunotherapy research Leading companies:  F. Hoffmann-La Roche Ltd  Novartis AG  Biogen  Teva Pharmaceutical Industries Ltd  Amgen, Inc Market challenges include adverse drug effects, strict regulatory requirements, and risks of infections in patients using immunomodulatory treatments. Report- Fortune Business Insights - Immunomodulators Market Size, Share, Trends, Analysis, 2027 https://www.fortunebusinessinsights.com/immunomodulators-market-104692

More Related